László Márk

Lipid, blood pressure and kidney update 2013

Antithrombotic Therapy for Venous Thromboembolic Disease

Oral Anticoagulant Therapy

Sex and gender: modifiers of health, disease, and medicine

GRADE guidelines: 3. Rating the quality of evidence

Changing life expectancy in central Europe: is there a Single reason?

Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy

Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment

Curcumin: A Review of Its Effects on Human Health

The Enlargement of the European Union and NATO

Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary

An attempt to make lipid-lowering therapy more effective in Hungary. The results of MULTI GAP 2010 and the Plus Program

How can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia guidelines?

Cytochrome P450 2C9 polymorphism and acenocoumarol therapy.

An attempt to evaluate the risk factors related to coronary heart disease in Hungary.